5,556 Shares in DENTSPLY SIRONA Inc (XRAY) Purchased by Front Barnett Associates LLC

Front Barnett Associates LLC bought a new position in DENTSPLY SIRONA Inc (NASDAQ:XRAY) in the third quarter, HoldingsChannel.com reports. The firm bought 5,556 shares of the medical instruments supplier’s stock, valued at approximately $210,000.

A number of other large investors have also recently added to or reduced their stakes in XRAY. Skandinaviska Enskilda Banken AB publ lifted its stake in shares of DENTSPLY SIRONA by 5.1% in the 3rd quarter. Skandinaviska Enskilda Banken AB publ now owns 35,062 shares of the medical instruments supplier’s stock valued at $1,323,000 after acquiring an additional 1,700 shares during the last quarter. S&CO Inc. lifted its stake in shares of DENTSPLY SIRONA by 11.3% in the 3rd quarter. S&CO Inc. now owns 55,342 shares of the medical instruments supplier’s stock valued at $2,089,000 after acquiring an additional 5,640 shares during the last quarter. Icon Advisers Inc. Co. bought a new stake in shares of DENTSPLY SIRONA in the 3rd quarter valued at about $1,517,000. John G Ullman & Associates Inc. bought a new stake in shares of DENTSPLY SIRONA in the 3rd quarter valued at about $5,340,000. Finally, Rockefeller Capital Management L.P. lifted its stake in shares of DENTSPLY SIRONA by 1,941.8% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 3,369 shares of the medical instruments supplier’s stock valued at $127,000 after acquiring an additional 3,204 shares during the last quarter. 97.90% of the stock is owned by institutional investors and hedge funds.

A number of equities research analysts have recently weighed in on XRAY shares. BidaskClub lowered DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Wednesday, July 18th. Zacks Investment Research lowered DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Monday, August 6th. Robert W. Baird lowered DENTSPLY SIRONA from an “outperform” rating to a “neutral” rating and lowered their target price for the company from $56.00 to $38.00 in a research note on Tuesday, August 7th. Stephens lowered DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $75.00 target price for the company. in a research note on Wednesday, August 8th. Finally, Morgan Stanley lowered DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $54.00 to $40.00 in a research note on Wednesday, August 8th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and six have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $51.50.

XRAY opened at $36.06 on Friday. The company has a market cap of $7.90 billion, a price-to-earnings ratio of 13.56, a price-to-earnings-growth ratio of 2.06 and a beta of 1.15. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.69 and a quick ratio of 1.10. DENTSPLY SIRONA Inc has a one year low of $33.93 and a one year high of $68.98.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, November 8th. The medical instruments supplier reported $0.38 EPS for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.08). The business had revenue of $928.40 million for the quarter, compared to the consensus estimate of $951.58 million. DENTSPLY SIRONA had a negative net margin of 39.62% and a positive return on equity of 9.12%. The company’s revenue for the quarter was down 8.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.70 EPS. Equities research analysts forecast that DENTSPLY SIRONA Inc will post 2.07 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “5,556 Shares in DENTSPLY SIRONA Inc (XRAY) Purchased by Front Barnett Associates LLC” was reported by Transcript Daily and is owned by of Transcript Daily. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States & international trademark and copyright laws. The original version of this piece of content can be read at https://transcriptdaily.com/2018/11/10/5556-shares-in-dentsply-sirona-inc-xray-purchased-by-front-barnett-associates-llc.html.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

See Also: How Short Selling Works

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply